Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pelthos Therapeutics (PTHS) Non Operating Income (2024 - 2025)

Pelthos Therapeutics has reported Non Operating Income over the past 2 years, most recently at -$16.6 million for Q4 2025.

  • Quarterly results put Non Operating Income at -$16.6 million for Q4 2025, down 16157.84% from a year ago — trailing twelve months through Dec 2025 was -$18.3 million (down 4660.89% YoY), and the annual figure for FY2025 was -$18.3 million, down 4659.38%.
  • Non Operating Income for Q4 2025 was -$16.6 million at Pelthos Therapeutics, down from -$1.3 million in the prior quarter.
  • Over the last five years, Non Operating Income for PTHS hit a ceiling of $354000.0 in Q3 2024 and a floor of -$16.6 million in Q4 2025.